EUVIMEDEUVIMED entdecken
Crossref

Behavior Prediction in Signaling Networks: Modeling of p16-Mediated Pathway

Rza Bashirov

Advances in Experimental Medicine and Biology · 2026 · 75-89

DOI: 10.1007/978-3-032-20041-9_5 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advances in Experimental Medicine and Biology, online erschienen am 25.05.2026. Verfasst von Rza Bashirov. Beteiligte Einrichtung: Department of Mathematics, Eastern Mediterranean University, Famagusta, North Cyprus, Mersin-10, Turkey. rza.bashirov@emu.edu.tr. Hauptthemen laut MEDLINE: Signal Transduction, Models, Biological, Cyclin-Dependent Kinase Inhibitor p16. Die Arbeit nennt 14 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Signal TransductionModels, BiologicalCyclin-Dependent Kinase Inhibitor p16Stochastic ProcessesComputer SimulationAnimalsFuzzy LogicKineticsHumansPrediction Algorithms

Stichwörter der Autor:innen

Fuzzy setQuantitative modelingSimulation-based behavior predictionStochastic simulationp16-mediated signaling pathway

Substanzen

Cyclin-Dependent Kinase Inhibitor p16

Autor:innen und Institutionen

  • Department of Mathematics, Eastern Mediterranean University, Famagusta, North Cyprus, Mersin-10, Turkey. rza.bashirov@emu.edu.tr.

Zitieren

APA

Bashirov, R. (2026). Behavior Prediction in Signaling Networks: Modeling of p16-Mediated Pathway. Advances in Experimental Medicine and Biology, 75-89. https://doi.org/10.1007/978-3-032-20041-9_5

Vancouver

Bashirov R. Behavior Prediction in Signaling Networks: Modeling of p16-Mediated Pathway. Advances in Experimental Medicine and Biology. 2026:75-89. doi:10.1007/978-3-032-20041-9_5

BibTeX
@article{Bashirov2026,
  author = {Bashirov, Rza},
  title = {Behavior Prediction in Signaling Networks: Modeling of p16-Mediated Pathway},
  journal = {Advances in Experimental Medicine and Biology},
  year = {2026},
  pages = {75--89},
  doi = {10.1007/978-3-032-20041-9_5}
}
Kostenlos starten →